Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder

NCT: NCT07463703 · RECRUITING

NCT IDNCT07463703
StatusRECRUITING
Start Date2026-08-14
Completion2027-01
SponsorCognitive FX (INDUSTRY)
First posted
Last updated

Brief Summary

This study tests a new brain stimulation treatment for post-traumatic stress disorder (PTSD), a condition that affects millions after trauma, causing symptoms like flashbacks, avoidance, mood changes, and heightened alertness. The investigators will enroll 15 adults (ages 18-65) with PTSD. First, participants get a brain scan (fMRI) to map their unique brain connections between areas involved in fear and control-the right amygdala (fear center) and right dorsolateral prefrontal cortex (control area). Using this personalized map, the investigators will apply accelerated transcranial magnetic stimulation (TMS), a safe, non-invasive method using magnetic pulses to adjust brain activity. Treatment lasts 5 days (10 short sessions daily, totaling 90,000 pulses) targeting the identified spot to strengthen control over fear responses. The study checks if this approach is practical, safe (tracking side effects like headaches), and shows early signs of reducing PTSD symptoms (measured by questionnaires and interviews). Follow-up lasts 3 months, with repeat scans to see brain changes. This study will see if personalized, fast-paced TMS targeting the disrupted fear-control brain circuit in PTSD can be feasible and safe, and preliminarily reduce symptoms by improving brain connectivity, potentially offering a quicker alternative to standard treatments.

Frequently Asked Questions

What is Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder?

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder is a clinical trial registered under NCT07463703. Current status: RECRUITING.

What is the status of NCT07463703?

The current status of NCT07463703 (Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder) is: RECRUITING.

When did Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder start?

Accelerated Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder started on 2026-08-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.